manufacturing defects – Page 10

Carton print error during inspection – recall risk analysis

Analyzing Carton Print Errors During Inspection: A Comprehensive Investigation In pharmaceutical manufacturing, a carton print error can pose significant compliance and safety risks, especially during final product inspections. Such errors…

Glass vial crack during stability testing – packaging vs process investigation

Investigation of Glass Vial Cracks During Stability Testing: Packaging or Process? Encountering cracks in glass vials during stability testing poses a significant challenge in pharmaceutical manufacturing. This problem not only…

Stopper coring after transport simulation – CAPA ineffectiveness

Addressing Stopper Coring After Transport Simulation: An Effective CAPA Approach The integrity of pharmaceutical products relies heavily on appropriate packaging, and stopper coring post-transport simulation is a critical manufacturing defect…

Crimp seal defect after transport simulation – packaging vs process investigation

Investigation of Crimp Seal Defects After Transport Simulation: Processes vs. Packaging In the pharmaceutical industry, ensuring the integrity of packaging is paramount, particularly when it comes to crimp seals that…

CCIT failure during inspection – regulatory risk assessment

Assessing Risks from CCIT Failures During Inspection: An Investigative Approach In the pharmaceutical industry, the integrity of packaging is paramount to ensure product effectiveness and patient safety. A failure in…

Stopper coring after supplier change – packaging vs process investigation

Investigating Stopper Coring Following a Supplier Change: A Comprehensive Approach In the realm of pharmaceutical manufacturing, the integrity of packaging components is critical to maintaining product quality and safety. One…

Container leakage after transport simulation – regulatory risk assessment

Assessing Container Leakage Post-Transport: A Comprehensive Investigation When containers exhibit leakage following transport simulation, it raises significant concerns for pharmaceutical manufacturers regarding product integrity, regulatory compliance, and patient safety. This…

Crimp seal defect during stability testing – CAPA ineffectiveness

Investigating Crimp Seal Defects During Stability Testing: Ensuring CAPA Effectiveness The integrity of pharmaceutical products during stability testing is paramount, and defects in crimp seals can lead to questions about…

Container leakage after supplier change – CAPA ineffectiveness

CAPA Ineffectiveness in Addressing Container Leakage Following a Supplier Change In the pharmaceutical manufacturing environment, effective packaging is critical for product integrity and safety. This article addresses a prevalent issue…

CCIT failure after supplier change – CAPA ineffectiveness

Addressing CCIT Failures Post Supplier Change: An Investigative Approach When a Controlled Container Integrity Test (CCIT) failure is reported following a supplier change, it can signal significant underlying issues that…

Crimp seal defect during stability testing – regulatory risk assessment

Addressing Crimp Seal Defects in Stability Testing: A Comprehensive Investigation Crimp seal defects during stability testing can have significant implications for pharmaceutical manufacturing quality and regulatory compliance. Such defects may…

Container leakage during stability testing – packaging vs process investigation

Addressing Container Leakage During Stability Testing: A Comprehensive Investigation Approach Container leakage during stability testing can present significant challenges for pharmaceutical manufacturers, ranging from product quality concerns to regulatory compliance…